Cambrex Wiesbaden
Our specialist team in Wiesbaden has strong expertise in enzyme screening and developed more than 800 proprietary enzymes of different classes.
About the plant
Consisting of nine employees, our specialist team in Wiesbaden has strong expertise in enzyme screening and developed more than 800 proprietary enzymes of different classes. For easy implementation of biocatalytic conversion, our customers are provided with fully optimized processes and all technical support required.
Through efficient and environmentally friendly enzymatic syntheses, we can manufacture highly pure regio-, chemo-, and enantioselective intermediates and APIs for our customers in a cost-efficient way.
Problematic chemicals, such as CN waste, can be degraded to harmless compounds.
Facility Details
- 1000 strains (yeast, bacteria, fungi, algae)
- In-house cultivation, screening, cloning, and gene discovery
- In-house lab scale enzyme production
- Multi-ton scale enzyme production with external partners
Certifications
Activity
- Peptide, protein, hormone & enzyme, BIOLOGICS manufacturing
Features
- Uses: Investigational, Commercial (Phase IV), Preclinical, Phase I, Phase II, Phase III, Human
- Toxicity (OEB classification):
- DEA: N/A
- BSL:
- Therapeutic areas: N/A
- Markets: FDA (USA), EMA (EU)
Batch Size / Reactor
- Small, Medium, Large, 1 - 10 sqm, 10 - 50 sqm, 50 - 100 sqm, 100 - 200 sqm
Services
- Development services, Analytical / QC services, Logistics, R&D, QbD (Quality by Design), Process development, Process optimization, Process validation, Lyophilization cycle development, Stability studies design, Stability studies execution, ICH Stability studies, Comparability studies, Downstream, Analytical methods development, Analytical methods validation, Release testing of raw materials, Release testing of product, Analytical methods transfer, Storage, Distribution
Address: Rheingaustrasse 190-196, 65203, Wiesbaden, Germany
United States
Year: 1998
Other plants of this company
Cambrex LongmontCambrex Longmont location specializes in the early development of small molecule pharmaceutical products in a fully integrated drug substance and drug product facility.
Cambrex Waterford (Q1 Scientific)Q1 Scientific Ltd., a Cambrex Company, provides environmentally controlled cGMP stability storage services for the pharmaceutical, medical device, and life science industries.
Cambrex High PointCambrex High Point focuses on the development and manufacture of active pharmaceutical ingredients (APIs) to support clinical trials from Phase I to Phase III, as well as small-scale commercial manufacturing.
Contact the CDMO commercial and technical team directly
Contact us
If you have any questions or suggestions, click here. We will be happy to assist you.
